(BEAM) Beam Therapeutics - Performance -22.4% in 12m
Compare BEAM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-25.72%
#42 in Group
Rel. Strength
32.76%
#5351 in Universe
Total Return 12m
-22.44%
#58 in Group
Total Return 5y
-16.71%
#33 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -26.46%
(?) Percentile in Group
12m Total Return: BEAM (-22.4%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BEAM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BEAM
| Total Return (including Dividends) | BEAM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 18.64% | 11.81% | 13.81% |
| 3 Months | -35.08% | -13.61% | -6.30% |
| 12 Months | -22.44% | -12.29% | 10.65% |
| 5 Years | -16.71% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | BEAM | XBI | S&P 500 |
| 1 Month | 40.5% | 72.9% | 83% |
| 3 Months | -84.7% | -83% | -75.3% |
| 12 Months | -9.30% | -51.6% | 50.1% |
| 5 Years | -56.4% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #82 | 6.11% | 4.24% |
| 3 Month | #113 | -24.9% | -30.7% |
| 12 Month | #59 | -11.6% | -29.9% |
| 5 Years | #33 | 10.9% | -59.9% |
FAQs
Does BEAM Beam Therapeutics outperforms the market?
No,
over the last 12 months BEAM made -22.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months BEAM made -35.08%, while XBI made -13.61%.
Over the last 3 months BEAM made -35.08%, while XBI made -13.61%.
Performance Comparison BEAM vs Indeces and Sectors
BEAM vs. Indices BEAM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -14.2% | 4.83% | -31.3% | -33.1% |
| US NASDAQ 100 | QQQ | -14.4% | 1.28% | -31.5% | -34.1% |
| US Dow Jones Industrial 30 | DIA | -14.6% | 8.65% | -31.0% | -30.2% |
| German DAX 40 | DAX | -14.2% | 3.68% | -57.6% | -48.1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -16.4% | 6.81% | -32.1% | -29.8% |
| Hongkong Hang Seng | HSI | -17.4% | -1.29% | -39.7% | -36.1% |
| India NIFTY 50 | INDA | -9.27% | 13.8% | -31.8% | -22.2% |
| Brasil Bovespa | EWZ | -15.2% | 1.40% | -40.0% | -14.1% |
BEAM vs. Sectors BEAM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -14.8% | 5.23% | -38.4% | -44.0% |
| Consumer Discretionary | XLY | -14.6% | 4.41% | -30.3% | -36.7% |
| Consumer Staples | XLP | -13.3% | 12.1% | -38.2% | -31.6% |
| Energy | XLE | -14.0% | 11.9% | -24.7% | -13.0% |
| Financial | XLF | -15.3% | 5.12% | -38.4% | -44.9% |
| Health Care | XLV | -11.2% | 17.8% | -26.3% | -18.4% |
| Industrial | XLI | -15.9% | 1.82% | -32.7% | -33.4% |
| Materials | XLB | -14.0% | 5.08% | -26.4% | -17.2% |
| Real Estate | XLRE | -12.9% | 7.10% | -32.1% | -37.9% |
| Technology | XLK | -15.3% | -2.58% | -28.4% | -29.5% |
| Utilities | XLU | -14.2% | 9.05% | -39.0% | -39.9% |
| Aerospace & Defense | XAR | -16.2% | -2.52% | -42.8% | -49.8% |
| Biotech | XBI | -7.60% | 6.83% | -11.2% | -10.2% |
| Homebuilder | XHB | -14.7% | 7.16% | -18.1% | -14.9% |
| Retail | XRT | -16.1% | 3.99% | -27.1% | -21.0% |